Clinical Trials Directory

Trials / Terminated

TerminatedNCT06854432

Assessment of Biological and Biometrological Parameters in Adult Subjects with Androgenetic Alopecia

Multi-omics Approaches and Biometrological Analyses to Better Understand Androgenetic Alopecia: Exploratory Study

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
46 (actual)
Sponsor
Pierre Fabre Dermo Cosmetique · Industry
Sex
Male
Age
30 Years – 50 Years
Healthy volunteers
Accepted

Summary

Androgenetic alopecia is a chronic pathology affecting approximately 50% of men at 50 years old and is characterized by a progressive miniaturization of the hair follicle leading to a localized baldness. Although it has been shown that testosterone metabolism plays a central role in this pathology, targeting this biological pathway is not fully efficient to treat androgenetic alopecia, suggesting that other factors are involved, notably factors linked to the perifollicular environment. Moreover, the very specific pattern of androgenetic alopecia is not yet fully understood: the occipital and lower temporal areas of the scalp are always preserved. Once the hair follicle has disappeared, it is not possible to make it grow back, it is then important to provide a treatment that slows down the progression of androgenetic alopecia at the earliest stage of the pathology, and that specifically targets the affected area. The aim of this study is to better understand androgenetic alopecia pathophysiology by a multi-omic approaches and biometrological analysis, in the same study, on the local ecosystem of bald scalp areas and non-bald scalp areas of adult with androgenetic alopecia, compared to scalp of adult without androgenetic alopecia.

Conditions

Interventions

TypeNameDescription
OTHERBiometrological measurementsMeasurements will be taken from the scalp: on the vertex and occiput areas.
OTHERBiological samplingSamples will be taken from the scalp: on the vertex and occiput areas.

Timeline

Start date
2024-03-05
Primary completion
2024-04-25
Completion
2024-04-25
First posted
2025-03-03
Last updated
2025-03-03

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06854432. Inclusion in this directory is not an endorsement.